The effect of neoadjuvant chemotherapy with gemcitabine and S-1 for resectable pancreatic cancer (randomized phase II/III trial; Prep-02/JSAP-05).

Authors

null

Sohei Satoi

Department of Surgery, Kansai Medical University, Hirakata, Japan

Sohei Satoi , Michiaki Unno , Fuyuhiko Motoi , Yutaka Matsuyama , Ippei Matsumoto , Suefumi Aosasa , Hirofumi Shirakawa , Keita Wada , Tsutomu Fujii , Hideyuki Yoshitomi , Shinichiro Takahashi , Masayuki Sho , Hideki Ueno , Tomohisa Yamamoto , Tomoo Kosuge

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Pancreatic Cancer

Clinical Trial Registration Number

UMIN000009634

Citation

J Clin Oncol 37, 2019 (suppl; abstr 4126)

DOI

10.1200/JCO.2019.37.15_suppl.4126

Abstract #

4126

Poster Bd #

231

Abstract Disclosures

Similar Posters

First Author: Michiaki Unno

First Author: Amit Jethanandani

First Author: Sameer H. Patel